Table 1 Cis-associated gene-SNP pairs with a nominal significant effect on methylphenidate response in the GWAS analysis.

From: Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder

Gene

Chra

Start baseb

Stop basec

SNP

SNP based

Risk allele

OR (95% CI)

GWAS P-value

Beta

eQTL P-value

eQTL adjusted P-value (FDR)e

SPSB2

12

6870935

6873357

rs12302749

6867132

T

2.31 (1.22–4.39)

0.011

0.115

3.34e-08

1.13e-05

PYROXD2

10

98383565

98415221

rs1061115

98417292

G

2.23 (1.13–4.41)

0.021

−0.088

1.28e-06

2.17e-04

ARSA

22

50622754

50628173

rs2071421

50625988

T

2.56 (1.06–6.22)

0.037

0.104

8.26e-06

7.26e-04

RRP7A

22

42508335

42519823

rs11553441

42516091

C

3.13 (1.15–8.54)

0.026

0.177

1.04e-05

7.26e-04

CHURC1

14

64914361

64935368

rs4902333

64909368

T

2.37 (1.24–4.51)

8.73e-03

0.116

1.07e-05

7.26e-04

GGH

8

63015079

63039051

rs17279558

63015187

C

3.61 (1.12–11.7)

0.032

0.130

2.38e-04

0.013

SENP3

17

7561992

7571969

rs9901673

7580783

A

3.95 (1.79–8.71)

6.53e-04

0.052

4.66e-04

0.023

PEBP4

8

22713251

22941095

rs17685420

22927888

T

2.87 (1.38–5.94)

4.62e-03

−0.073

9.72e-04

0.041

STRBP

9

123109494

123268576

rs9032

123104493

C

2.28 (1.07–4.85)

0.033

0.071

2.15e-03

0.081

ETFDH

4

158672101

158708713

rs11559290

158680524

C

2.08 (1.01–4.28)

0.048

−0.048

2.57e-03

0.087

CORO7

16

4354542

4416961

rs3810818

4382028

A

2.10 (1.13–3.94)

0.020

−0.053

3.17e-03

0.098

FXR2

17

7591230

7614897

rs9901675

7581494

A

4.12 (1.32–12.9)

0.015

0.130

3.84e-03

0.107

NFIB

9

14081843

14398983

rs7858

14087770

C

2.89 (1.02–8.19)

0.045

−0.055

4.12e-03

0.107

ALDH1L1

3

126103561

126181526

rs2886059

126146923

C

2.73 (1.04–7.14)

0.041

−0.078

5.31e-03

0.129

OPCML

11

132403361

133532983

rs751655

132623600

C

3.08 (1.18–8.02)

0.022

−0.063

7.43e-03

0.158

PURA

5

140114123

140119416

rs2013169

140118020

T

3.32 (1.23–9.01)

0.018

0.071

7.45e-03

0.158

ZDHHC7

16

84974460

85011732

rs3210967

84975857

C

2.09 (1.11–3.94)

0.023

0.056

8.03e-03

0.160

WRB

21

39380287

39397889

rs3761372

39371919

T

3.38 (1.39–8.22)

7.36e-03

0.071

8.54e-03

0.161

FARP2

2

241356249

241494842

rs757978

241431686

C

5.18 (1.19–22.6)

0.029

0.062

0.010

0.181

SENP3

17

7561992

7571969

rs11552708

7559238

A

3.81 (1.50–9.72)

5.05e-03

0.041

0.011

0.189

ZNF565

19

36182060

36215084

rs4805162

36183403

G

2.24 (1.19–4.22)

0.012

0.034

0.016

0.255

ESYT2

7

158730998

158829628

rs1061735

158733764

G

2.91 (1.10–7.67)

0.031

0.030

0.017

0.255

HTT

4

3074510

3243960

rs362272

3233253

G

2.40 (1.06–5.42)

0.035

−0.033

0.019

0.276

CMTM8

3

32238679

32370325

rs4627790

32259860

C

1.98 (1.07–3.68)

0.030

0.054

0.021

0.298

ZNF134

19

57614219

57624717

rs10413455

57620255

A

5.75 (1.35–24.4)

0.018

0.061

0.024

0.323

PDIA2

16

283118

287209

rs1048786

286916

C

3.55 (1.19–10.6)

0.023

−0.087

0.027

0.345

PIGM

1

160027672

160031993

rs12409352

160030645

A

2.67 (1.00–7.12)

0.049

0.029

0.032

0.395

TRIB3

20

380629

397559

rs2295490

388261

G

2.06 (1.06–4.00)

0.033

0.092

0.034

0.406

ZNF211

19

57633167

57644046

rs10420097

57633193

G

7.29 (1.82–29.3)

5.18e-03

0.084

0.038

0.439

ARHGAP12

10

31805398

31928876

rs2799018

31913141

T

1.89 (1.00–3.56)

0.049

−0.036

0.039

0.446

ARHGEF28

5

73626158

73941993

rs929740

73621913

G

2.52 (1.31–4.84)

5.40e-03

−0.037

0.042

0.453

CDH23

10

71396934

71815947

rs17712523

71777857

G

2.61 (1.05–6.48)

0.039

−0.073

0.045

0.475

ELP5

17

7252053

7259940

rs4562

7260420

A

2.22 (1.24–3.95)

6.95e-03

−0.031

0.048

0.497

  1. Note: SNP, single-nucleotide polymorphism; GWAS, genome-wide association study; Chr, gene chromosomal location; OR, odds ratio; CI, confidence interval; eQTL, expression quantitative trait loci.
  2. a,b,c,dAll relative to the human reference genome GRCh38 (NCBI Build 38).
  3. eSignificance threshold for the False Discovery Rate (FDR) correction at P < 0.05.